Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 255

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Clinical Intestinal Transplantation: New Perspectives and Immunologic Considerations 1 1This study was supported in part by Project Grant No. DK 29661 from the National Institutes of Health, Bethesda, MD.

Open access
Abu-Elmagd, Kareem, Reyes, Jorge, Todo, Satoru, Rao, Abdul, Lee, Randall, Irish, William, Furukawa, Hiro, Bueno, Javier, McMichael, John, Fawzy, Ahmed T, Murase, Noriko, Demetris, Jake, Rakela, Jorge, Fung, John J, Starzl, Thomas E·1998·Journal of the American College of Surgeons

Abstract

BACKGROUND: Although tacrolimus-based immunosuppression has made intestinal transplantation feasible, the risk of the requisite chronic high-dose treatment has inhibited the widespread use of these procedures. We have examined our 1990-1997 experience to determine whether immunomodulatory strategies to improve outlook could be added to drug treatment. STUDY DESIGN: Ninety-eight consecutive patients (59 children, 39 adults) with a panoply of indications received 104 allografts under tacrolimus-based immunosuppression: intestine only (n = 37); liver and intestine (n = 50); or multivisceral (n = 17). Of the last 42 patients, 20 received unmodified adjunct donor bone marrow cells; the other 22 were contemporaneous control patients. RESULTS: With a mean followup of 32 +/- 26 months (range, 1-86 months), 12 recipients (3 intestine only, 9 composite grafts) are alive with good nutrition beyond the 5-year milestone. Forty-seven (48%) of the total group survive bearing grafts that provide full (91%) or partial (9%) nutrition. Actuarial patient survival at 1 and 5 years (72% and 48%, respectively) was similar with isolated intestinal and composite graft recipients, but the loss rate of grafts from rejection was highest with intestine alone. The best results were in patients between 2 and 18 years of age (68% at 5 years). Adjunct bone marrow did not significantly affect the incidence of graft rejection, B-cell lymphoma, or the rate or severity of graft-versus-host disease. CONCLUSIONS: These results demonstrate that longterm rehabilitation similar to that with the other kinds of organ allografts is achievable with all three kinds of intestinal transplant procedures, that the morbidity and mortality is still too high for their widespread application, and that the liver is significantly but marginally protective of concomitantly engrafted intestine. Although none of the endpoints were markedly altered by donor leukocyte augmentation (and chimerism) with bone marrow, establishment of the safety of this adjunct procedure opens the way to further immune modulation strategies that can be added to the augmentation protocol.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1072-7515(98)00083-0

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 255

Metadata

Authors
Abu-Elmagd, K., Reyes, J., Todo, S., Rao, A., Lee, R., Irish, W., Furukawa, H., Bueno, J., McMichael, J., Fawzy, A. T., Murase, N., Demetris, J., Rakela, J., Fung, J. J., & Starzl, T. E.
Venue
Journal of the American College of Surgeons
Published
1998-05
Volume
186
Issue
5
Pages
512-527
ISSN
1072-7515 (ISSN-L)
OpenAlex
W2112796160
Cited by
255
References
28
FWCI
27.74
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Intestinal Transplantation: New Perspectives and Immunologic Considerations 1 1This study was supported in part by Project Grant No. DK 29661 from the National Institutes of Health, Bethesda, MD. https://app.cochat.ai/papers/10.1016/s1072-7515(98)00083-0
The paper
Abu-Elmagd, K., Reyes, J., Todo, S., Rao, A., Lee, R., Irish, W., Furukawa, H., Bueno, J., McMichael, J., Fawzy, A. T., Murase, N., Demetris, J., Rakela, J., Fung, J. J., & Starzl, T. E. (1998). Clinical Intestinal Transplantation: New Perspectives and Immunologic Considerations 1 1This study was supported in part by Project Grant No. DK 29661 from the National Institutes of Health, Bethesda, MD. Journal of the American College of Surgeons. https://doi.org/10.1016/s1072-7515(98)00083-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.